NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Start Free »

DOCS | NYSE

$26.52 $0.32 | 1.22%

SIGNAL:

|2026-09-29 |F&G 62 |RSI 55.4

Add to favoritesFavorite

Company Overview:

Market Cap: $4.84B

Trailing PE: 31.2x

FWD PE *: 19x

Payout Ratio (TTM): —

52-Week Range: $17.15 - $75.44

* Forward PE is based on street estimates.

5.3 Year DOCS Performance Metrics:

Total Return (with DRIP): -50.0% (-12.25% CAGR)

Total Return (no DRIP): -50.0% (-12.25% CAGR)

Share Price: -50.0% (-12.25% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $5,004

Total Return $ (with DRIP): -$4,996

DOCS Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

DOCS Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

DOCS Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

DOCS - Revenue

DOCS Revenue CAGR:1Y: 7.34%2Y: 11.19%5Y: 16.60%10Y: 0.00%

DOCS - Earnings Per Share (EPS)

DOCS EPS CAGR:1Y: -51.85%2Y: -21.32%5Y: 17.52%10Y: 0.00%

DOCS - Net Income

🔓 See the full chart40% off right now · 7-day free trial

DOCS Net Income CAGR:1Y: -54.40%2Y: -23.34%5Y: -1.57%10Y: 0.00%

DOCS - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

DOCS EBITDA CAGR:1Y: -43.44%2Y: -17.57%5Y: 7.75%10Y: 0.00%

DOCS - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

DOCS Free Cash Flow CAGR:1Y: -34.14%2Y: 0.08%5Y: 4.12%10Y: 0.00%

DOCS - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

DOCS Free Cash Flow / Share CAGR:1Y: -28.21%2Y: 3.83%5Y: 5.27%10Y: 0.00%

DOCS - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

DOCS Operating Income CAGR:1Y: -38.29%2Y: -14.53%5Y: 6.23%10Y: 0.00%

DOCS - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

DOCS Gross Profit CAGR:1Y: 2.16%2Y: 8.40%5Y: 15.50%10Y: 0.00%

DOCS - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

DOCS Shares Outstanding CAGR:1Y: -4.97%2Y: -2.04%5Y: -0.64%10Y: 0.00%

DOCS - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

DOCS Share Buybacks CAGR:1Y: -25.11%2Y: 33.76%5Y: 102.40%10Y: 0.00%

DOCS - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

DOCS Stock-Based Comp CAGR:1Y: 68.09%2Y: 46.65%5Y: 48.28%10Y: 0.00%

DOCS - Expenses

🔓 See the full chart40% off right now · 7-day free trial

DOCS Expenses CAGR:1Y: -96.85%2Y: -80.93%5Y: -40.22%10Y: 0.00%

DOCS - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

DOCS - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

DOCS - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

DOCS - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

DOCS - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

DOCS - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

DOCS - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

DOCS Revenue CAGR:1Y: 7.34%2Y: 11.19%5Y: 16.60%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

DOCS - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

DOCS Actual Revenue CAGR:1Y: 7.34%2Y: 11.19%5Y: 16.60%10Y: 0.00%

DOCS - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

DOCS Actual EPS CAGR:1Y: -51.85%2Y: -21.32%5Y: 17.52%10Y: 0.00%

DOCS - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

DOCS Actual Net Income CAGR:1Y: -54.40%2Y: -23.34%5Y: -1.57%10Y: 0.00%

DOCS - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

DOCS Actual EBITDA CAGR:1Y: -43.44%2Y: -17.57%5Y: 7.75%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

DOCS - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

DOCS Net Profit Margin CAGR:1Y: -57.50%2Y: -31.04%5Y: -15.58%10Y: 0.00%

DOCS - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

DOCS Gross Profit Margin CAGR:1Y: -4.83%2Y: -2.51%5Y: -0.95%10Y: 0.00%

DOCS - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

DOCS Price to Earnings CAGR:1Y: -27.18%2Y: 13.04%5Y: -30.77%10Y: 0.00%

DOCS - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

DOCS Price To Sales Ratio CAGR:1Y: -69.41%2Y: -22.50%5Y: -30.20%10Y: 0.00%

DOCS - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

DOCS Return on Capital Employed CAGR:1Y: -30.95%2Y: -14.31%5Y: 1.13%10Y: 0.00%

DOCS - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

DOCS Return on Invested Capital CAGR:1Y: -49.97%2Y: -24.61%5Y: -8.65%10Y: 0.00%

Projected Future Returns & Dividends for DOCS

Based on past 5.3-year performance, here are DOCS growth metrics:

Share price CAGR of -12.25%
Dividend CAGR of +0%

Using DOCS CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	DOCS (DRIP)	DOCS - No DRIP
Current Price	$26.52	$26.52
Start Shares	377.07	377.07
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	377.07	377.07
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$7.18	$26.52
Total Dividends	$0	$0
Final Value	$2,708	$10,000

Estimated Future Value + Dividends - DOCS

NOTE: Above numbers are our estimate based on DOCS's Dividend and Price CAGR over past 5.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

Company Info

Doximity, Inc. (DOCS) had its IPO on 2021-06-24, and is traded on NYSE stock exchange.

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

DOCS website: https://www.doximity.com

Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

DCF Model — DOCS

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $26.52

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →